The Journal of Neurobehavioral Sciences

The Journal of Neurobehavioral Sciences

A novel treatment option for autism spectrum disorder: vasopressin receptor antagonists

Yazarlar: Çöpür Mazlum, Çöpür Sidar

Cilt 7 , Sayı 2 , 2020 , Sayfalar 98-100

Konular:-

DOI:10.4103/JNBS.JNBS_4_20

Anahtar Kelimeler:-

Özet: Autism spectrum disorder is a developmental disability affecting 1 in every 59 newborns and causes significant morbidity while exact pathophysiology is unclear. Recent hypothesis includes vasopressin in patients with ASD while vasopressin receptor antagonists including balovaptan appears to be promising option for treatment especially in ASD patients with high functionality. In this study, our aim is to describe recent developments in vasopressin receptor antagonists involving ASD treatment which have potential for future clinical implementation.

ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır
KAYNAK GÖSTER
BibTex
KOPYALA
@article{2020, title={A novel treatment option for autism spectrum disorder: vasopressin receptor antagonists}, volume={7}, number={98–100}, publisher={The Journal of Neurobehavioral Sciences}, author={Çöpür Mazlum,Çöpür Sidar}, year={2020} }
APA
KOPYALA
Çöpür Mazlum,Çöpür Sidar. (2020). A novel treatment option for autism spectrum disorder: vasopressin receptor antagonists (Vol. 7). Vol. 7. The Journal of Neurobehavioral Sciences.
MLA
KOPYALA
Çöpür Mazlum,Çöpür Sidar. A Novel Treatment Option for Autism Spectrum Disorder: Vasopressin Receptor Antagonists. no. 98–100, The Journal of Neurobehavioral Sciences, 2020.
Atıf Görüntüle
PDF Görüntüle
Kaynak Görüntüle
Paylaş
Dergi Bilgileri